Literature DB >> 32303734

Antibody tests suggest that coronavirus infections vastly exceed official counts.

Smriti Mallapaty.   

Abstract

Entities:  

Year:  2020        PMID： 32303734     DOI： 10.1038/d41586-020-01095-0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

1.  Random-Forest-Bagging Broad Learning System With Applications for COVID-19 Pandemic.

Authors:  Choujun Zhan; Yufan Zheng; Haijun Zhang; Quansi Wen
Journal:  IEEE Internet Things J       Date:  2021-03-17       Impact factor: 10.238

2.  COVID-19 infection: Disease detection and mobile technology.

Authors:  Jaya Verma; Amar Shankar Mishra
Journal:  PeerJ       Date:  2020-11-09       Impact factor: 2.984

3.  Comprehensive identification and isolation policies have effectively suppressed the spread of COVID-19.

Authors:  Yubo Huang; Yan Wu; Weidong Zhang
Journal:  Chaos Solitons Fractals       Date:  2020-06-20       Impact factor: 9.922

4.  Assessing the effect of containment measures on the spatio-temporal dynamic of COVID-19 in Italy.

Authors:  Maria Michela Dickson; Giuseppe Espa; Diego Giuliani; Flavio Santi; Lucia Savadori
Journal:  Nonlinear Dyn       Date:  2020-08-08       Impact factor: 5.741

5.  National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance.

Authors:  Muthusamy Santhosh Kumar; Tarun Bhatnagar; Ponnaiah Manickam; V Saravana Kumar; Kiran Rade; Naman Shah; Shashi Kant; Giridhara R Babu; Sanjay Zodpey; C P Girish Kumar; Jeromie Wesley Vivian Thangaraj; Pranab Chatterjee; Suman Kanungo; Ravindra Mohan Pandey; Manoj Murhekar; Sujeet K Singh; Swarup Sarkar; J P Muliyi; Raman R Gangakhedkar; D C S Reddy
Journal:  Indian J Med Res       Date:  2020-05       Impact factor: 2.375

6.  Comparative Study of COVID-19 Pandemic Progressions in 175 Regions in Australia, Canada, Italy, Japan, Spain, U.K. and USA Using a Novel Model That Considers Testing Capacity and Deficiency in Confirming Infected Cases.

Authors:  Choujun Zhan; Chi K Tse; Ying Gao; Tianyong Hao
Journal:  IEEE J Biomed Health Inform       Date:  2021-08-05       Impact factor: 5.772

Review 7.  [Seroprevalence and SARS-CoV-2 testing in healthcare occupations].

Authors:  Focke Ziemssen; Tarek Bayyoud; Karl Ulrich Bartz-Schmidt; Andreas Peter; Marius Ueffing
Journal:  Ophthalmologe       Date:  2020-07       Impact factor: 1.174

8.  COVID-19: test, trace and isolate-new epidemiological data.

Authors:  Harald Brüssow
Journal:  Environ Microbiol       Date:  2020-06-27       Impact factor: 5.476

9.  Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward.

Authors:  Bonnie E Shook-Sa; Ross M Boyce; Allison E Aiello
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

Review 10.  [The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)].

Authors:  Burkhard L Herrmann
Journal:  MMW Fortschr Med       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.